Dipyridamole 50mg tid
2025-451-02
Phase 3 small_molecule active
Quick answer
Dipyridamole 50mg tid for Restless Leg Syndrome Due to Uraemia is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Restless Leg Syndrome Due to Uraemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active